Fortrea Holdings Inc. (FTRE) vs Immunome, Inc. (IMNM)

A side-by-side comparison of Fortrea Holdings Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fortrea Holdings Inc. logo
FTRE
Fortrea Holdings Inc.
$2.06B
$21.65HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
Immunome, Inc. logo
IMNM
Immunome, Inc.
$1.93B
$20.17HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

Total return — FTRE vs IMNM

growth of $100 · dividends reinvested · last 3y
FTRE -34.0% (-12.9%/yr)IMNM +265.6% (+54.1%/yr)IMNM compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202420252026$66$366
FTRE IMNM

FTRE vs IMNM: by the numbers

  • •FTRE is the larger company ($2.06B vs $1.93B market cap).
  • •Both run net losses; FTRE's is the smaller (-3.18% vs -3059.99% net margin).

Metrics side by side

Valuation

MetricFTREIMNM
Forward P/E25.73N/A
P/S ratio0.77N/A
P/B ratio3.933.67
EV / EBITDA33.68N/A
FCF yield7.32%N/A

Profitability

MetricFTREIMNM
Gross margin17.11%57.43%
Operating margin0.41%-3084.76%
Net margin-3.18%-3059.99%
ROE-16.25%-48.43%
ROIC0.62%-51.06%

Growth (annualized)

MetricFTREIMNM
Revenue CAGR (5Y)1.09%N/A
FCF CAGR (5Y)-12.98%N/A
Total return CAGR (5Y)N/A2.88%

Go deeper

Full FTRE analysisFull IMNM analysisInteractive comparison tool

Dig into the metrics

Fortrea ROEImmunome ROEFortrea operating marginImmunome operating marginFortrea revenue growthImmunome revenue growthFortrea free cash flowImmunome free cash flow

Fortrea & Immunome appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.